SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16642920
Source:
http://linkedlifedata.com/resource/pubmed/id/16642920
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002335
,
umls-concept:C0007202
,
umls-concept:C0020966
,
umls-concept:C0599946
,
umls-concept:C0684336
pubmed:issue
4
pubmed:dateCreated
2006-4-28
pubmed:abstractText
It is well documented that cardiopulmonary bypass (CPB) severely impairs cellular immunity. The objective of this study was to investigate the effect of prostaglandin E1 (PGE1) on cellular immunity after CPB.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100884261
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alprostadil
,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione
,
http://linkedlifedata.com/resource/pubmed/chemical/Phytohemagglutinins
,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Tuberculin
,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1344-4964
pubmed:author
pubmed-author:MasudaMunetakaM
,
pubmed-author:MoritaShigekiS
,
pubmed-author:SanoTetsuroT
,
pubmed-author:YasuiHisatakaH
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-54
pubmed:meshHeading
pubmed-meshheading:16642920-Aged
,
pubmed-meshheading:16642920-Alprostadil
,
pubmed-meshheading:16642920-Cardiopulmonary Bypass
,
pubmed-meshheading:16642920-Cell Proliferation
,
pubmed-meshheading:16642920-Female
,
pubmed-meshheading:16642920-Glutathione
,
pubmed-meshheading:16642920-Heart Diseases
,
pubmed-meshheading:16642920-Humans
,
pubmed-meshheading:16642920-Immunity, Cellular
,
pubmed-meshheading:16642920-Leukocytes, Mononuclear
,
pubmed-meshheading:16642920-Male
,
pubmed-meshheading:16642920-Middle Aged
,
pubmed-meshheading:16642920-Oxidative Stress
,
pubmed-meshheading:16642920-Phytohemagglutinins
,
pubmed-meshheading:16642920-Platelet Aggregation Inhibitors
,
pubmed-meshheading:16642920-T-Lymphocytes
,
pubmed-meshheading:16642920-Time Factors
,
pubmed-meshheading:16642920-Treatment Outcome
,
pubmed-meshheading:16642920-Tuberculin
,
pubmed-meshheading:16642920-Vasodilator Agents
pubmed:year
2006
pubmed:articleTitle
Prostaglandin E1 attenuates impairment of cellular immunity after cardiopulmonary bypass.
pubmed:affiliation
Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial